DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,254 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,253 | -99.9% | 61,479 | -5.0% | 0.74% | +2.9% |
| Q2 2023 | $15,534,960 | -53.2% | 64,729 | -50.8% | 0.72% | -16.9% |
| Q1 2023 | $33,181,066 | +119.0% | 131,650 | +130.6% | 0.87% | +0.6% |
| Q4 2022 | $15,150,970 | -10.5% | 57,083 | -13.0% | 0.86% | -16.0% |
| Q3 2022 | $16,937,000 | +4.3% | 65,576 | +2.4% | 1.03% | +11.2% |
| Q2 2022 | $16,235,000 | -27.9% | 64,040 | -16.6% | 0.92% | -0.8% |
| Q1 2022 | $22,514,000 | -14.9% | 76,754 | -4.6% | 0.93% | -3.4% |
| Q4 2021 | $26,458,000 | +2.0% | 80,417 | -5.6% | 0.96% | -7.1% |
| Q3 2021 | $25,945,000 | +7.2% | 85,223 | -5.5% | 1.04% | +10.2% |
| Q2 2021 | $24,210,000 | +17.3% | 90,212 | -1.6% | 0.94% | +8.4% |
| Q1 2021 | $20,645,000 | +0.7% | 91,725 | -0.7% | 0.87% | -5.5% |
| Q4 2020 | $20,510,000 | -9.7% | 92,332 | -12.5% | 0.92% | -24.1% |
| Q3 2020 | $22,710,000 | +15.3% | 105,464 | -5.3% | 1.21% | +7.1% |
| Q2 2020 | $19,693,000 | +28.6% | 111,364 | +0.7% | 1.13% | -2.8% |
| Q1 2020 | $15,313,000 | -19.9% | 110,637 | -11.2% | 1.17% | +9.7% |
| Q4 2019 | $19,123,000 | -5.0% | 124,593 | -10.6% | 1.06% | -16.2% |
| Q3 2019 | $20,123,000 | +3.6% | 139,326 | +2.5% | 1.27% | +2.1% |
| Q2 2019 | $19,427,000 | +7.0% | 135,929 | -1.1% | 1.24% | +3.2% |
| Q1 2019 | $18,152,000 | +31.3% | 137,493 | +2.5% | 1.21% | +10.0% |
| Q4 2018 | $13,829,000 | -4.9% | 134,108 | +0.3% | 1.10% | +18.0% |
| Q3 2018 | $14,536,000 | +10.0% | 133,773 | -0.1% | 0.93% | +3.6% |
| Q2 2018 | $13,218,000 | +0.3% | 133,948 | -0.5% | 0.90% | -1.1% |
| Q1 2018 | $13,183,000 | +8.1% | 134,648 | +2.5% | 0.91% | +11.0% |
| Q4 2017 | $12,199,000 | +13.5% | 131,423 | +4.8% | 0.82% | +11.2% |
| Q3 2017 | $10,752,000 | -18.5% | 125,348 | -19.8% | 0.74% | -14.1% |
| Q2 2017 | $13,188,000 | -3.0% | 156,281 | -1.7% | 0.86% | -0.8% |
| Q1 2017 | $13,600,000 | +22.8% | 159,006 | +11.8% | 0.86% | +18.7% |
| Q4 2016 | $11,071,000 | -0.5% | 142,221 | +0.2% | 0.73% | +3.0% |
| Q3 2016 | $11,125,000 | -17.9% | 141,921 | +5.7% | 0.71% | -19.6% |
| Q2 2016 | $13,557,000 | -2.1% | 134,224 | -8.0% | 0.88% | -2.8% |
| Q1 2016 | $13,841,000 | -13.9% | 145,911 | -15.7% | 0.90% | -10.6% |
| Q4 2015 | $16,071,000 | +5.8% | 173,025 | -2.9% | 1.01% | -0.9% |
| Q3 2015 | $15,184,000 | -35.1% | 178,185 | -34.8% | 1.02% | +2.3% |
| Q2 2015 | $23,381,000 | +40.5% | 273,175 | +39.3% | 1.00% | +2.2% |
| Q1 2015 | $16,643,000 | -4.5% | 196,040 | -3.5% | 0.98% | -8.1% |
| Q4 2014 | $17,420,000 | +12.5% | 203,250 | -0.2% | 1.06% | +11.2% |
| Q3 2014 | $15,478,000 | -7.6% | 203,705 | -4.3% | 0.95% | -4.3% |
| Q2 2014 | $16,759,000 | -3.9% | 212,868 | -8.4% | 1.00% | -2.3% |
| Q1 2014 | $17,436,000 | -4.3% | 232,475 | -1.5% | 1.02% | -2.2% |
| Q4 2013 | $18,221,000 | +14.5% | 236,031 | +2.8% | 1.04% | +6.5% |
| Q3 2013 | $15,911,000 | -99.9% | 229,526 | +4.7% | 0.98% | +11.9% |
| Q2 2013 | $13,880,487,000 | – | 219,281 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |